HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lancaster signs Lopez

This article was originally published in The Rose Sheet

Executive Summary

Jennifer Lopez's Sweetface Fashion Company has signed a licensing agreement with Lancaster to develop and market fragrance and cosmetics under the J.Lo brand, Coty's prestige division announces March 15. Slated to launch in the fall, line initially will roll out in U.S., UK, Germany, Austria and Switzerland to select department stores and specialty stores where J.Lo fashions are sold, Lancaster adds. "Products will be designed to reflect the inspirational, confident and desirable qualities of Jennifer Lopez herself," firm says...

You may also be interested in...



Coty Signs Licensing Agreement With Urban Label Baby Phat

Coty is aiming to capitalize on the youth-oriented "urban market" by launching a collection of fragrances under the Baby Phat by Kimora Lee Simmons and Phat Farm brands, the firm said. The company announced it signed a licensing agreement with Simmons Sept. 10

Lancaster Looking To Shine With Jennifer Lopez Glow

Coty's prestige division Lancaster is aiming to cash in on the success of superstar Jennifer Lopez with the introduction of the singer/actress' premier fragrance, a women's scent called Glow

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010123

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel